Cardiovascular pharmacology of ASL-8052, an ultra-short acting β blocker
- 1 October 1983
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 94 (1-2) , 43-51
- https://doi.org/10.1016/0014-2999(83)90440-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.Heart, 1981
- NadololDrugs, 1980
- The clinical pharmacology of beta-adrenoceptor-blocking drugsProgress in Cardiovascular Diseases, 1976
- Adverse Effects of ??-Adrenergic Receptor Blocking Drugs on Respiratory FunctionDrugs, 1974
- Adverse Reactions to ??-Adrenergic Receptor Blocking DrugsDrugs, 1974
- Cardiac Effects of -Adrenergic Receptor AntagonistsPublished by S. Karger AG ,1973
- Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonistsLife Sciences, 1973
- Integrative neural cardiovascular control.Physiological Reviews, 1971
- Acute and Chronic Effects of an Adrenergic Beta-Receptor Blocking Agent (Propranolol) in Treatment of Cardiac ArrhythmiasCirculation, 1966
- Role of aortic and vagus nerves in arterial baroreflex bradycardia in rabbitsAmerican Journal of Physiology-Legacy Content, 1963